Borderline Personality Disorder & Polygraph Testing Guide

A Clinical Overview of BPD

Borderline personality disorder (BPD) is a complex mental health condition characterized by pervasive patterns of instability in interpersonal relationships, self-image, emotions, and marked impulsivity [1]Verified Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies
Confirms BPD prevalence ranges from 0.7% to 2.7% in general population, 22% among psychiatric inpatients, and details DSM-5 diagnostic criteria. Classified in the DSM-5 as a Cluster B personality disorder, BPD has a point prevalence of approximately 1.4% according to NIMH data based on the National Comorbidity Survey Replication [2]Verified Personality Disorders — National Institute of Mental Health (NIMH)
Confirms BPD point prevalence of 1.4% based on the National Comorbidity Survey Replication, while the Grant et al. (2008) NESARC study reported a lifetime prevalence of 5.9% [3]Verified Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder: Results From the Wave 2 NESARC
Confirms lifetime BPD prevalence of 5.9% in the NESARC Wave 2 study of 34,653 adults, though this figure has been contested by later reanalyses using stricter criteria. A 2025 systematic review and meta-analysis found a pooled prevalence of 2.41% (95% CI: 1.70%–3.40%), with individual study estimates ranging from 0.7% to 7.35% [4]Verified Epidemiology of borderline personality disorder in the general population: Prevalence, sociodemographic factors, and comorbidities — A systematic review and meta-analysis
Confirms pooled BPD prevalence of 2.41% (95% CI: 1.70%–3.40%) across 12 community-based studies. The wide range reflects differences in diagnostic methodology, with stricter impairment requirements producing lower estimates [3]Verified Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder: Results From the Wave 2 NESARC
Confirms lifetime BPD prevalence of 5.9% in the NESARC Wave 2 study of 34,653 adults, though this figure has been contested by later reanalyses using stricter criteria.

BPD is diagnosed when an individual meets at least five of nine DSM-5 criteria [1]Verified Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies
Confirms BPD prevalence ranges from 0.7% to 2.7% in general population, 22% among psychiatric inpatients, and details DSM-5 diagnostic criteria: frantic efforts to avoid real or imagined abandonment; unstable and intense interpersonal relationships alternating between idealization and devaluation; identity disturbance with markedly unstable self-image; impulsivity in at least two potentially self-damaging areas; recurrent suicidal behavior, gestures, or self-mutilating behavior; emotional instability due to marked mood reactivity; chronic feelings of emptiness; inappropriate, intense anger or difficulty controlling anger; and transient, stress-related paranoid ideation or severe dissociative symptoms.

From a neurobiological perspective, research has identified structural and functional differences in the brains of individuals with BPD. Neuroimaging meta-analyses consistently show heightened amygdala reactivity coupled with diminished prefrontal cortex activity [5]Verified Neural Correlates of Disturbed Emotion Processing in Borderline Personality Disorder: A Multimodal Meta-Analysis
Confirms heightened amygdala activity and reduced prefrontal cortex function in BPD through functional and structural neuroimaging meta-analysis. These neurological differences are central to understanding why BPD presents unique challenges in polygraph testing — the very brain regions responsible for emotional regulation and autonomic control are structurally and functionally altered.

BPD Versus Other Personality Disorders

It is important for polygraph examiners to distinguish BPD from other Cluster B personality disorders that also affect testing. While narcissistic personality disorder (NPD) is characterized by grandiosity and lack of empathy, and antisocial personality disorder (ASPD) involves persistent disregard for others' rights, BPD is fundamentally defined by emotional instability and fear of abandonment.

Antisocial Personality Disorder: Individuals may show dampened autonomic responses due to low physiological arousal, potentially producing false negatives. Research on pathological lying demonstrates the distinct cognitive patterns in ASPD that differ from BPD.

Narcissistic Personality Disorder: Grandiosity and self-serving cognitive distortions can affect how questions are perceived and processed, but the core autonomic instability seen in BPD is typically absent.

Borderline Personality Disorder: The primary challenge is autonomic instability itself — the physiological baseline that the polygraph relies upon is inherently unstable, creating interpretation difficulties that differ fundamentally from those posed by NPD or ASPD.

Understanding these distinctions is essential because the protocols and accommodations required for BPD differ significantly from those used with other conditions in the Cluster B spectrum. Research on cognitive, social, and personality processes in deception detection confirms that personality factors independently shape polygraph detectability [6]Verified Cognitive, Social, and Personality Processes in the Physiological Detection of Deception
Confirms that personality factors (socialization, electrodermal lability) and meprobamate independently affect polygraph detectability.

The Fundamental Challenge: Unstable Physiological Baselines

Polygraph testing relies on measuring and comparing physiological responses across different types of questions. The instrument typically records three primary channels of physiological activity: respiratory patterns (thoracic and abdominal pneumograph components), electrodermal activity (galvanic skin response), and cardiovascular activity (blood pressure, pulse rate, and pulse amplitude). Understanding these channels is fundamental to the principles of applied psychophysiology and polygraph testing.

The underlying premise is that deception-related cognitive processing produces detectable changes in these physiological channels relative to a stable baseline. For individuals with BPD, this fundamental requirement — a reasonably stable physiological baseline — is precisely what the disorder disrupts.

The emotional dysregulation characteristic of BPD manifests as measurable autonomic nervous system instability. A meta-analysis by Koenig et al. (2016) demonstrated that individuals with BPD show significantly lower resting state vagally-mediated heart rate variability (vmHRV) compared to healthy controls (Hedges' g = -0.59, 95% CI [-1.11; -0.06]) [7]Verified Resting State Vagal Tone in Borderline Personality Disorder: A Meta-Analysis
Confirms BPD shows lower resting state vmHRV relative to healthy controls (Hedges' g=-0.59), suggesting reduced parasympathetic activity. This reduced vagal tone indicates a sympathetic nervous system that is partially activated even before any stressor is introduced, creating a noisy baseline against which deception-related responses become harder to detect.

Prevalence in Testing Populations

While BPD affects approximately 1.4% of the general population by point prevalence [2]Verified Personality Disorders — National Institute of Mental Health (NIMH)
Confirms BPD point prevalence of 1.4% based on the National Comorbidity Survey Replication, its prevalence is significantly higher in certain populations that commonly undergo polygraph testing. According to NIMH, BPD prevalence in the general adult population ranges between 0.7% and 2.7% [1]Verified Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies
Confirms BPD prevalence ranges from 0.7% to 2.7% in general population, 22% among psychiatric inpatients, and details DSM-5 diagnostic criteria, but in psychiatric settings rates climb to approximately 12% among outpatients and 22% among inpatients [1]Verified Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies
Confirms BPD prevalence ranges from 0.7% to 2.7% in general population, 22% among psychiatric inpatients, and details DSM-5 diagnostic criteria.

In criminal justice settings, BPD prevalence is substantially elevated. A 2024 systematic review and meta-analysis of BPD in prison populations found prevalence rates of 27.4% for women and 18.8% for men via diagnostic interview [8]Verified Global prevalence of borderline personality disorder and self-reported symptoms of adults in prison: A systematic review and meta-analysis
Confirms BPD prevalence in prison of 27.4% for women and 18.8% for men via diagnostic interview. Earlier research reports rates generally ranging between 25% and 50% depending on the study and assessment method [9]Verified Borderline Personality and Criminality
Confirms BPD rates in prison populations generally range between 25% and 50%, with higher rates among women. One study found that 27% of male and 55% of female prisoners met diagnostic criteria for BPD [9]Verified Borderline Personality and Criminality
Confirms BPD rates in prison populations generally range between 25% and 50%, with higher rates among women. The overall prevalence of BPD in the U.S. prison population is estimated at approximately 17% [10]Verified Borderline personality disorder — Wikipedia
Confirms BPD point prevalence of 1.6% and lifetime prevalence of 5.9% globally, and overall U.S. prison prevalence of approximately 17%.

This is particularly relevant for post-conviction sex offender testing (PCSOT) and other screening polygraph examinations, where personality disorders are diagnosed at much higher rates than in the general population. The implication is clear: BPD is not an edge case for professional polygraph examiners. In criminal justice, therapeutic, and supervision contexts, it is one of the most commonly encountered mental health conditions, making examiner competency in BPD-related protocols a professional necessity.

Understanding Emotional Dysregulation in BPD

Emotional dysregulation is the hallmark feature of BPD and the single most impactful factor in polygraph testing. Marsha Linehan's biosocial theory (1993), the leading etiological model of BPD, places emotion dysregulation at the core of the disorder. According to Linehan, individuals with BPD experience broad dysregulation across all aspects of emotional responding, resulting in three components: (a) heightened emotional sensitivity (low threshold for emotional response), (b) inability to regulate intense emotional responses, and (c) slow return to emotional baseline [11]Verified A Biosocial Developmental Model of Borderline Personality: Elaborating and Extending Linehan's Theory
Confirms Linehan's biosocial model describing BPD emotional dysregulation as (a) heightened sensitivity, (b) inability to regulate, and (c) slow return to baseline.

During a polygraph examination, this triad manifests in ways that directly challenge test validity. The heightened emotional sensitivity means that even neutral or comparison questions can trigger disproportionate physiological responses. The emotional hyperreactivity means that relevant questions may produce responses far exceeding what would be expected from deception alone. And the slow return to baseline means that physiological recovery between questions is delayed, creating carryover effects that contaminate subsequent question responses — a phenomenon that examiners must identify as artifacts in polygraph testing.

Understanding the fight-or-flight response in polygraph testing is essential context for appreciating how BPD amplifies these normal physiological processes.

Autonomic Nervous System Patterns in BPD

Research on autonomic nervous system function in BPD reveals a complex picture. The Koenig et al. (2016) meta-analysis found that BPD is associated with lower resting state vagally-mediated heart rate variability — a marker of diminished parasympathetic nervous system activity [7]Verified Resting State Vagal Tone in Borderline Personality Disorder: A Meta-Analysis
Confirms BPD shows lower resting state vmHRV relative to healthy controls (Hedges' g=-0.59), suggesting reduced parasympathetic activity. This finding has been confirmed by subsequent studies showing reduced vagal activity in BPD women compared to healthy controls [7]Verified Resting State Vagal Tone in Borderline Personality Disorder: A Meta-Analysis
Confirms BPD shows lower resting state vmHRV relative to healthy controls (Hedges' g=-0.59), suggesting reduced parasympathetic activity.

For the polygraph, this means the baseline physiological state is already elevated and variable. The cardiovascular measures that the polygraph records are particularly affected. Blood pressure fluctuations in BPD can occur spontaneously, unrelated to specific question stimuli, creating artifacts that complicate scoring. Electrodermal activity, which relies on sympathetic nervous system activation of sweat glands, is similarly affected — individuals with BPD may show spontaneous skin conductance responses outside of any question-related stimulus.

Respiratory patterns also present challenges. Individuals in heightened emotional states commonly exhibit irregular breathing, sighing respiration, or breath-holding — all of which the polygraph's pneumograph components will record. Distinguishing between anxiety-driven breathing irregularities (which are chronic in BPD) and deception-related respiratory changes requires exceptional skill and experience.

Fear of Abandonment and Examiner Dynamics

One BPD-specific factor often underappreciated in polygraph literature is the impact of the examiner-examinee relationship on testing dynamics. Individuals with BPD are intensely sensitive to perceived interpersonal cues and may rapidly develop idealized or devalued perceptions of the examiner during the pre-test phase. Research on deception detection expertise confirms that interpersonal dynamics significantly influence the examination process [12]Verified Deception Detection Expertise
Confirms that expert lie detectors achieved 80-90% accuracy using nonverbal behavioral cues with fast, intuitive judgments.

The fear of abandonment — a core BPD criterion — can manifest as intense anxiety about the examiner's reactions to their answers. An examinee with BPD may experience the polygraph examination itself as a potential abandonment event: if they fail the test, they fear losing their relationship, their freedom, their therapist's approval, or another attachment figure. This fear-driven arousal can produce consistent elevations across all question types, making it extremely difficult to differentiate between deception-related responses and abandonment-fear-related responses.

Research shows that experts who achieve high accuracy in detecting deception rely on nonverbal behavioral cues and fast, intuitive judgments [12]Verified Deception Detection Expertise
Confirms that expert lie detectors achieved 80-90% accuracy using nonverbal behavioral cues with fast, intuitive judgments. However, the atypical nonverbal presentation of BPD examinees can complicate these assessments.

Types and Prevalence of Dissociation in BPD

Dissociation is one of the nine DSM-5 diagnostic criteria for BPD. Research indicates that dissociation occurs in approximately two-thirds of people with BPD [13]Verified Dissociation and borderline personality disorder: an update for clinicians
Confirms dissociation occurs in about two-thirds of people with BPD, though the exact prevalence varies depending on the definition used. A 2025 study found that depending on the definition, one-third to one-quarter of BPD patients experience significant dissociative phenomena [14]Verified Trait dissociation in borderline personality disorder: influence on immediate therapy outcomes, follow-up assessments, and self-harm patterns
Confirms that one-third to one-quarter of BPD patients experience significant dissociative phenomena depending on definition used. A major systematic scoping review of 70 studies found that dissociation was consistently associated with increased BPD symptom severity, self-harm, and reduced psychotherapy treatment response [15]Verified A systematic scoping review of dissociation in borderline personality disorder and implications for research and clinical practice
Confirms dissociation is associated with increased BPD symptom severity, self-harm, and reduced therapy response across 70 studies.

The Scalabrini et al. (2017) meta-analytic review, published in the Journal of Trauma & Dissociation, found that levels of dissociation are higher in BPD than in other psychiatric disorders in general, although this difference was moderate and the heterogeneity of effect sizes was large [16]Verified The Extent of Dissociation in Borderline Personality Disorder: A Meta-Analytic Review
Confirms higher levels of dissociation in BPD than other psychiatric disorders, with moderate effect sizes and large heterogeneity. Importantly, individuals with BPD showed higher levels of dissociation than those with several psychiatric and personality disorders, but not dissociative disorders or PTSD [16]Verified The Extent of Dissociation in Borderline Personality Disorder: A Meta-Analytic Review
Confirms higher levels of dissociation in BPD than other psychiatric disorders, with moderate effect sizes and large heterogeneity.

For polygraph purposes, the most relevant forms of dissociation include depersonalization (detachment from one's body or feelings), derealization (the environment feels unreal or dreamlike), emotional numbing (shutdown of emotional processing), and dissociative amnesia (inability to recall normally accessible information). Each form creates distinct challenges for polygraph interpretation.

How Dissociation Distorts Polygraph Data

The impact of dissociation on polygraph data depends on the type and severity of the dissociative episode. In general, dissociation tends to flatten or blunt the physiological responses that the polygraph measures, creating a pattern opposite to what emotional dysregulation produces. This creates a paradoxical situation: the same individual may produce wildly variable physiological data during emotionally activated phases and then shift to flat, non-reactive tracings during dissociative episodes — sometimes within the same examination session.

When dissociation produces blunted responses to relevant questions, the result may be a false negative — the individual appears truthful because they are not producing expected deception-related physiological responses. However, this lack of response does not indicate truthfulness; it indicates psychological disconnection from the content of the questions. Understanding what constitutes a significant response in polygraph testing helps examiners recognize when dissociation may be producing artificially flat tracings.

Examiners should be trained to recognize behavioral indicators of dissociation during testing, including: fixed or glazed stare, delayed or confused responses to questions, monotone or flat vocal quality, reports of feeling foggy or not really here, sudden shifts from agitation to apparent calm, and loss of awareness of the testing environment. When these indicators are observed, the examination should be paused and the examinee's fitness to continue reassessed.

Splitting in the Polygraph Context

Splitting — the tendency to perceive people, events, and situations in dichotomous, all-or-nothing terms — is one of the most recognizable features of BPD. During the pre-test interview, an examinee who is splitting may describe the same events with dramatically different emotional valence depending on their current idealization or devaluation phase. For example, an examinee being tested about an incident involving their partner might describe them as wonderful at the beginning of the pre-test interview, only to shift to describing them in extremely negative terms 20 minutes later after an emotionally triggering question.

Both characterizations are genuinely believed in the moment, which complicates the examiner's ability to formulate questions the examinee will process consistently. This relates to broader patterns explored in why liars believe their own lies — though in BPD, the issue is not self-deception per se, but genuinely shifting perception driven by emotional state.

Identity Disturbance and Self-Referential Questions

Identity disturbance — a markedly and persistently unstable self-image or sense of self — is another core BPD criterion with direct implications for polygraph testing. Questions that require self-reference (Have you ever..., Did you..., Are you the type of person who...) rely on the examinee having a stable sense of who they are. For individuals with BPD, self-concept can shift based on emotional state and relational context.

This creates a specific challenge for comparison question formulation. Comparison questions are designed to evoke a known or expected response that serves as a physiological comparison point. If the examinee's self-concept is unstable, their processing of comparison questions may vary unpredictably, undermining the comparison methodology fundamental to modern techniques such as the Federal Zone Comparison Technique. Examinees have the right to request specific polygraph techniques, which may be relevant when BPD accommodations are needed.

For examiners working with BPD examinees, questions should be concrete, specific, and anchored to observable behaviors rather than relying on self-characterization or emotional interpretation.

Emotional Flashbacks and Memory

Emotional flashbacks represent another BPD-specific challenge. Unlike PTSD flashbacks, which typically involve vivid sensory re-experiencing of a specific traumatic event, emotional flashbacks in BPD involve sudden, intense re-experiencing of past emotional states without necessarily recalling the specific events that originally triggered those emotions.

An individual having an emotional flashback during a polygraph examination may suddenly experience overwhelming fear, shame, or rage unrelated to the current questions — but the physiological markers of these emotions will be recorded by the polygraph instruments. These flashbacks can be triggered by any element of the testing environment: the examiner's tone of voice, the content of a question, the physical sensation of the pneumograph tubes, or the power dynamic inherent in the examiner-examinee relationship. The psychological toll of being falsely accused can compound these effects in examinees with BPD who have prior trauma history.

Common BPD Medication Classes

While there is no FDA-approved medication specifically for BPD, several classes of psychiatric medications are commonly prescribed to manage specific BPD symptoms [1]Verified Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies
Confirms BPD prevalence ranges from 0.7% to 2.7% in general population, 22% among psychiatric inpatients, and details DSM-5 diagnostic criteria. Each class has distinct effects on the autonomic nervous system functions that the polygraph measures. Examinees should know how to prepare for a polygraph exam, including disclosing all medications to the examiner.

Mood Stabilizers (Lithium, Valproate, Lamotrigine): Mood stabilizers are prescribed to reduce emotional intensity and mood swings. They modulate neurotransmitter activity and can dampen the amplitude of autonomic nervous system responses. For polygraph testing, physiological responses to both relevant and comparison questions may be reduced in magnitude, potentially making it harder to detect significant differences between question types. Lithium in particular has well-documented effects on cardiac conduction that can alter cardiovascular tracings.

Atypical Antipsychotics (Quetiapine, Olanzapine, Aripiprazole): Prescribed for impulsivity, anger, and transient psychotic symptoms in BPD, atypical antipsychotics have significant sedating and autonomic effects. Research confirms that clozapine, olanzapine, and quetiapine have significant affinity for muscarinic receptors in vitro, demonstrating clinically significant dose-dependent anticholinergic activity within their therapeutic range [17]Verified A model of anticholinergic activity of atypical antipsychotic medications
Confirms clozapine, olanzapine, and quetiapine have clinically significant dose-dependent anticholinergic activity within therapeutic range. However, the anticholinergic properties of quetiapine are debated in the literature — its unmetabolized form appears to have limited anticholinergic properties, with its active metabolite norquetiapine being primarily responsible for muscarinic receptor antagonism [18]Verified Delirium Induced by Quetiapine and the Potential Role of Norquetiapine
Confirms unmetabolized quetiapine has limited anticholinergic properties, with its metabolite norquetiapine having medium- to high-affinity muscarinic receptor antagonism. These medications can reduce heart rate, blood pressure, and electrodermal activity, potentially producing suppressed EDA tracings.

Benzodiazepines (Clonazepam, Lorazepam, Diazepam): Although their use in BPD is controversial due to abuse potential, benzodiazepines are sometimes prescribed for acute anxiety. These medications enhance GABA activity, producing widespread CNS depression that dampens virtually all autonomic responses. Research has shown that meprobamate (a related anxiolytic) dramatically reduced polygraph detectability [6]Verified Cognitive, Social, and Personality Processes in the Physiological Detection of Deception
Confirms that personality factors (socialization, electrodermal lability) and meprobamate independently affect polygraph detectability. Testing an individual taking benzodiazepines presents serious validity concerns, as the medication may suppress the very physiological responses the polygraph measures.

SSRIs and SNRIs: Commonly prescribed for comorbid depression and anxiety in BPD, these medications have moderate effects on autonomic function. SSRIs can reduce emotional reactivity over time, which may actually help stabilize physiological baselines and potentially improve test validity for BPD examinees.

Understanding Error Rates in BPD Examinees

Polygraph accuracy has been studied extensively. The American Polygraph Association's meta-analysis of 38 studies found that event-specific diagnostic testing produced an aggregated decision accuracy of 89% (confidence interval 83%–95%), with an inconclusive rate of 11% [19]Verified Polygraph Validity Research — American Polygraph Association Meta-Analysis
Confirms event-specific diagnostic testing accuracy of 89% (CI 83%-95%) and combined technique accuracy of 87% (CI 80%-94%). The combination of all validated techniques produced a decision accuracy of 87% (confidence interval 80%–94%) [19]Verified Polygraph Validity Research — American Polygraph Association Meta-Analysis
Confirms event-specific diagnostic testing accuracy of 89% (CI 83%-95%) and combined technique accuracy of 87% (CI 80%-94%). Polygraph proponents point to research indicating CQT accuracy of 90% or better [20]Verified Current status of forensic lie detection with the comparison question technique: An update of the 2003 National Academy of Sciences report on polygraph testing
Confirms polygraph proponents claim CQT accuracy of 90% or better, while the NAS 2003 report found scientific basis weak and error rate unknown, while the National Research Council's (2003) comprehensive review noted that accuracy estimates vary and cautioned about generalizability [20]Verified Current status of forensic lie detection with the comparison question technique: An update of the 2003 National Academy of Sciences report on polygraph testing
Confirms polygraph proponents claim CQT accuracy of 90% or better, while the NAS 2003 report found scientific basis weak and error rate unknown.

For individuals with BPD, several factors may shift these error rates. Emotional dysregulation tends to increase false positive risk — the examinee's heightened autonomic responses to all questions, including comparison questions, can produce patterns that mimic deception. Conversely, dissociation tends to increase false negative risk — blunted physiological responses during dissociative episodes may be interpreted as indicative of truthfulness when the individual is simply not processing the emotional significance of the questions.

Modern scoring methodologies, including empirical scoring systems, have demonstrated substantial inter-rater agreement. Research shows mean decision agreement of 95.4% excluding inconclusive results, significantly exceeding chance [21]Verified Reliability of the Empirical Scoring System with expert examiners
Confirms inter-rater agreement Fleiss kappa of.61 and mean decision agreement of 95.4% excluding inconclusive results. Multivariate statistical classifiers achieve accuracy equivalent to expert human evaluators [22]Verified Multivariate classifiers perform as well as experts in the detection of deception
Confirms statistical multivariate classifiers achieved accuracy equivalent to expert human evaluators on polygraph CQT data. However, these validation studies are conducted on general populations, and the specific challenges BPD presents to physiological baseline stability are not typically accounted for in standard accuracy estimates.

When to Consider Retesting

Given the variability of BPD symptoms, a single polygraph session may not capture the examinee's typical physiological profile. When results are inconclusive or the examiner suspects dissociation or extreme emotional dysregulation affected the data, a polygraph retest may be warranted. Retesting should ideally occur after consultation with the examinee's treating clinician and when the examinee is in a more stable emotional state.

The distinction between private and court-ordered polygraph examinations is important in BPD contexts. Private testing offers more flexibility for accommodations, while court-ordered testing may require documentation of BPD-related protocols to support the validity of results.

Fitness-for-Testing Assessment

Before proceeding with a polygraph examination of an examinee with known or suspected BPD, examiners should conduct a thorough fitness-for-testing assessment. The APA Standards of Practice state that examiners should make reasonable efforts to determine that the examinee is a suitable candidate for polygraph testing, and that mental, physical, or medical conditions observable or reasonably known to the examiner should be considered [23]Verified APA Bylaws and Standards of Practice
Confirms APA Standards of Practice effective 08/23/2024, requiring evidence-based validated techniques and suitability assessment of examinees.

This assessment should include: current medication status and timing of last dose; current emotional state and recent stressors; history of dissociative episodes and known triggers; presence of suicidal ideation (which requires immediate clinical referral, not polygraph testing); and whether the examinee has an active therapeutic relationship. If the examinee reports active suicidal ideation or appears to be in acute psychiatric crisis, the examination must be postponed and the appropriate clinical referral made.

Modified Testing Procedures

Several modifications can improve polygraph validity when testing individuals with BPD. Extended pre-test period: Allow additional time for the examinee to acclimate to the testing environment. This helps reduce baseline anxiety and allows the examiner to observe the examinee's emotional stability over a longer period.

Shorter question sequences: Reduce the number of questions per chart to minimize emotional buildup and carryover effects. The standard 20-second minimum interval between questions [23]Verified APA Bylaws and Standards of Practice
Confirms APA Standards of Practice effective 08/23/2024, requiring evidence-based validated techniques and suitability assessment of examinees may need to be extended for BPD examinees who show slow return to baseline.

Frequent baseline checks: Monitor physiological baselines between chart series and document any significant shifts that may indicate emotional dysregulation or dissociation onset.

Trauma-informed question language: Avoid question content or phrasing that might trigger emotional flashbacks or abandonment fears. Questions anchored to specific observable behaviors rather than emotional states or character judgments are preferable.

Consultation with treating clinician: With the examinee's consent, contact their therapist or psychiatrist to understand current symptom presentation, medication regimen, known triggers, and recommendations for managing potential dissociative episodes during testing.

Building Rapport Without Triggering Attachment Dynamics

The pre-test interview with a BPD examinee requires a careful balance. The examiner needs to establish sufficient rapport for the examinee to feel safe enough to engage honestly with the process, while avoiding the kind of interpersonal warmth that might trigger idealization or attachment dynamics. A neutral, professional, consistent demeanor is optimal.

Examiners should be aware that BPD examinees may attempt to test boundaries during the pre-test phase, may become emotionally volatile if they perceive the examiner as judgmental, and may need reassurance that the examination is not a personal evaluation of their worth. The examination room should be free of unnecessary stimuli that might trigger emotional responses.

Understanding why people lie provides useful context, but examiners should recognize that BPD examinees may not fit standard deception profiles — their physiological responses reflect emotional dysregulation as much as, or more than, any intent to deceive.

Question Development and Review

Questions for BPD examinees should be developed with particular attention to clarity and emotional neutrality. Each question should be reviewed with the examinee to ensure they understand the question as intended and to observe their emotional response to the content. If a question triggers visible emotional activation during the review phase, the examiner should note this and consider whether the question needs modification.

All questions should be concrete and behavioral (Did you take the money from the register on March 15th?) rather than abstract or characterological (Are you a dishonest person?). The emotional loading of questions should be minimized where possible without sacrificing diagnostic value.

PCSOT and BPD

Post-conviction sex offender testing represents one of the most common contexts where polygraph examiners encounter BPD. Given that BPD prevalence in prison populations ranges from approximately 17% to over 27% for women [8]Verified Global prevalence of borderline personality disorder and self-reported symptoms of adults in prison: A systematic review and meta-analysis
Confirms BPD prevalence in prison of 27.4% for women and 18.8% for men via diagnostic interview[10]Verified Borderline personality disorder — Wikipedia
Confirms BPD point prevalence of 1.6% and lifetime prevalence of 5.9% globally, and overall U.S. prison prevalence of approximately 17%, PCSOT examiners should be prepared to encounter BPD regularly. The APA promotes evidence-based validated testing techniques as a standard requirement [23]Verified APA Bylaws and Standards of Practice
Confirms APA Standards of Practice effective 08/23/2024, requiring evidence-based validated techniques and suitability assessment of examinees.

In the PCSOT context, the polygraph serves as an accountability and supervision tool rather than a purely forensic one. This distinction is important for BPD examinees, as the therapeutic relationship between the examinee, their treatment provider, and the supervision team can be leveraged to create conditions more conducive to valid testing. Regular communication between the polygraph examiner and the treatment provider ensures that testing is scheduled during periods of relative emotional stability.

Therapeutic Applications

In therapeutic contexts — including addiction recovery, couples therapy, and paternity doubt scenarios — polygraph can be a valuable accountability tool for individuals with BPD when appropriate clinical safeguards are in place. The key is ensuring that the polygraph examination is integrated into the broader treatment plan and that results are interpreted in the context of the individual's BPD symptomatology.

Therapists considering referring a BPD patient for polygraph testing should discuss the referral with the patient in advance, prepare the patient for the testing experience using distress tolerance skills from their DBT or other therapy, communicate directly with the polygraph examiner about the patient's presentation and needs, and be available for post-test processing of the patient's emotional response to the experience.

Admissibility and Weight of Results

The legal landscape for polygraph evidence is complex. Understanding why polygraph results are inadmissible in many courts provides important context. When a BPD diagnosis is known, attorneys should be prepared to challenge or support polygraph evidence based on whether appropriate accommodations were made during testing.

Forensic psychology experts, including those working at the intersection of law and psychology, can provide testimony about how BPD may have affected specific polygraph results. Courts that do consider polygraph evidence should weigh whether the examiner was aware of the BPD diagnosis, what accommodations were made, and whether the examiner consulted with the examinee's treating clinician.

The use of neuroimaging evidence in court remains an evolving area. Research has identified that no clear standard exists for determining which professionals are qualified to interpret such evidence [24]Verified Who Speaks for Neuroscience? Neuroimaging Evidence and Courtroom Expertise
Confirms no clear standard exists for determining which professionals are qualified to interpret neuroimaging evidence in court, a consideration relevant when BPD's neurobiological features are at issue.

Ethical Obligations

Polygraph examiners have an ethical obligation to consider the mental health of examinees. The APA Standards of Practice require that examiners make basic inquiries into the medical and psychological condition of the examinee and consider observable mental conditions when conducting and evaluating an examination [23]Verified APA Bylaws and Standards of Practice
Confirms APA Standards of Practice effective 08/23/2024, requiring evidence-based validated techniques and suitability assessment of examinees. For BPD examinees, this means documenting the BPD diagnosis in examination records, noting any behavioral indicators of dysregulation or dissociation observed during testing, providing context for unusual physiological patterns in examination reports, and recommending retesting when results may have been compromised by BPD symptoms.

Examiners should never use BPD as an automatic basis for refusing to test — this would represent discrimination against individuals with mental health conditions. Instead, the standard should be whether valid, interpretable results can be obtained with appropriate accommodations.